US OptionsDetailed Quotes

CASI250117C2500

Watchlist

1.35
0.000.00%

15min DelayClose Dec 31 16:00 ET

0.00High0.00Low

CASI Pharmaceuticals Stock Discussion

Stock_Drift

Dec 13, 2024 13:55

Low Floats 2:54pm

$DSS Inc (DSS.US)$ $Streamline Health Solutions (STRM.US)$ $Reborn Coffee (REBN.US)$ $SenesTech (SNES.US)$ $Jowell Global (JWEL.US)$ $CASI Pharmaceuticals (CASI.US)$ $iSpecimen (ISPC.US)$ $Nano Labs (NA.US)$ $Wheeler Real Estate Investment Trust Inc (WHLR.US)$ $Prestige Wealth (PWM.US)$ $VCI Global (VCIG.US)$
📊⚡️📊

Jaguar8

Oct 24, 2024 07:05

NEWS

$CASI Pharmaceuticals (CASI.US)$
CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia
CASI Pharmaceuticals (NASDAQ:CASI) has received Clinical Trial Application (CTA) approval from China's NMPA to conduct a phase 1/2 study of CID-103 in adult patients with chronic Immune Thrombocytopenia (ITP). The China study is part of a global study previously approved by the US FDA in May 2024. CID-103 is a fully human IgG1 anti-CD38 monoclonal antibody that...